Cargando…
High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
Autores principales: | Hafiane, Anouar, Ronca, Annalisa, Kiss, Robert S., Favari, Elda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086955/ https://www.ncbi.nlm.nih.gov/pubmed/35557540 http://dx.doi.org/10.3389/fcvm.2022.895031 |
Ejemplares similares
-
Measures of high-density lipoprotein function in men and women with severe aortic stenosis
por: Hafiane, Anouar, et al.
Publicado: (2022) -
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
por: Hafiane, Anouar, et al.
Publicado: (2015) -
High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020) -
Probucol alleviates atherosclerosis and improves high density lipoprotein function
por: Zhong, Jian-Kai, et al.
Publicado: (2011) -
Three polymethoxyflavones from the peel of Citrus reticulata “Chachi” inhibits oxidized low-density lipoprotein-induced macrophage-derived foam cell formation
por: Liang, Pu-Lin, et al.
Publicado: (2022)